Related Experiment Video
Updated: Jan 28, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
Role of FcγRs in Antibody-Based Cancer Therapy
Robert F Graziano1, John J Engelhardt2
1Oncology Discovery, Bristol-Myers Squibb, Princeton, NJ, Redwood City, CA, USA.
Abstract:
Monoclonal antibodies can mediate antitumor activity by multiple mechanisms. They can bind directly to tumor receptors resulting in tumor cell death, or can bind to soluble growth factors, angiogenic factors, or their cognate receptors blocking signals required for tumor cell growth or survival. Monoclonal antibodies, upon binding to tumor cell, can also engage the host's immune system to mediate immune-mediated destruction of the tumor. The Fc portion of the antibody is essential in engaging the host immune system by fixing complement resulting in complement-mediated cytotoxicity (CDC) of the tumor, or by engaging Fc receptors for IgG (FcγR) expressed by leukocytes leading to antibody-dependent cellular cytotoxicity (ADCC) or antibody-dependent cellular phagocytosis (ADCP) of tumor cells. Antibodies whose Fc portion preferentially engage activating FcγRs have shown greater inhibition of tumor growth and metastasis. Monoclonal antibodies can also stimulate the immune system by binding to targets expressed on immune cells. These antibodies may stimulate antitumor immunity by antagonizing a negative regulatory signal, agonizing a costimulatory signal, or depleting immune cells that are inhibitory. The importance of Fc:FcγR interactions in antitumor therapy for each of these mechanisms have been demonstrated in both mouse models and clinical trials and will be the focus of this chapter.
Insights
Monoclonal antibodies fight tumors directly or by engaging the immune system. The antibody
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Monoclonal antibodies (mAbs) offer versatile therapeutic strategies against cancer.
- mAbs can directly induce tumor cell death or block tumor growth signals.
- mAbs can also harness the host immune system for tumor cell destruction.
Purpose of the Study:
- To explore the multifaceted mechanisms of monoclonal antibody antitumor activity.
- To highlight the critical role of the Fc portion of antibodies in immune engagement.
- To review the significance of Fc:FcγR interactions in preclinical and clinical antitumor therapy.
Main Methods:
- Review of established mechanisms of mAb antitumor action.
- Discussion of Fc-mediated immune effector functions: complement-mediated cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP).
- Analysis of mAb-mediated immune system stimulation via immune cell targeting.
Main Results:
- Antibodies engaging activating Fcγ receptors demonstrate enhanced inhibition of tumor growth and metastasis.
- Fc:FcγR interactions are crucial for CDC, ADCC, and ADCP.
- mAbs targeting immune cells can modulate antitumor immunity by altering regulatory or costimulatory signals.
Conclusions:
- Monoclonal antibodies are potent tools in cancer immunotherapy, acting through diverse mechanisms.
- The Fc portion of mAbs is essential for mediating immune-dependent antitumor effects.
- Fc:FcγR interactions represent a key target for optimizing antibody-based cancer therapies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Role-Based Identity
Gene Therapy
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...

